Course: Utility of Mass SARS-CoV-2 Testing of Asymptomatic Patients Before Ambulatory and Inpatient Preplanned Procedures Requiring Moderate Sedation or General Anesthesia
CME Credits: 1.00
Released: 2021-06-25
Systematic management of procedures during the COVID-19 crisis is a priority to (1) detect and care appropriately for patients with COVID-19, (2) prevent outbreaks, and (3) safely maintain routine health care activities. SARS-CoV-2 presents unique challenges, as an estimated 50% of infections occur through asymptomatic transmission, and clinical screening may miss contagious patients.1,2 These factors complicate settings where aerosol-generating procedures (AGPs) are performed, potentially exposing health care personnel (HCP) to SARS-CoV-2 transmission. Furthermore, patients with COVID-19 have increased risks of postprocedural complications, and current guidelines suggest that testing asymptomatic patients prior to preplanned procedures may help to mitigate these risks.3 We describe our mass preprocedure SARS-CoV-2 nucleic acid amplification testing (NAAT) during a period of high community transmission.4
Educational Objective
To identify the key insights or developments described in this article
View Full Course